RANG_HUMAN - dbPTM
RANG_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID RANG_HUMAN
UniProt AC P43487
Protein Name Ran-specific GTPase-activating protein
Gene Name RANBP1
Organism Homo sapiens (Human).
Sequence Length 201
Subcellular Localization
Protein Description Plays a role in RAN-dependent nucleocytoplasmic transport. Alleviates the TNPO1-dependent inhibition of RAN GTPase activity and mediates the dissociation of RAN from proteins involved in transport into the nucleus (By similarity). Induces a conformation change in the complex formed by XPO1 and RAN that triggers the release of the nuclear export signal of cargo proteins. [PubMed: 20485264 Promotes the disassembly of the complex formed by RAN and importin beta. Promotes dissociation of RAN from a complex with KPNA2 and CSE1L (By similarity Required for normal mitotic spindle assembly and normal progress through mitosis via its effect on RAN]
Protein Sequence MAAAKDTHEDHDTSTENTDESNHDPQFEPIVSLPEQEIKTLEEDEEELFKMRAKLFRFASENDLPEWKERGTGDVKLLKHKEKGAIRLLMRRDKTLKICANHYITPMMELKPNAGSDRAWVWNTHADFADECPKPELLAIRFLNAENAQKFKTKFEECRKEIEEREKKAGSGKNDHAEKVAEKLEALSVKEETKEDAEEKQ
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MAAAKDTHE
------CCCCCCCCC
19.0019413330
5Acetylation---MAAAKDTHEDHD
---CCCCCCCCCCCC
59.4423954790
7Phosphorylation-MAAAKDTHEDHDTS
-CCCCCCCCCCCCCC
26.8526503892
13PhosphorylationDTHEDHDTSTENTDE
CCCCCCCCCCCCCCC
33.8422167270
14PhosphorylationTHEDHDTSTENTDES
CCCCCCCCCCCCCCC
39.5222167270
15PhosphorylationHEDHDTSTENTDESN
CCCCCCCCCCCCCCC
35.0322167270
18PhosphorylationHDTSTENTDESNHDP
CCCCCCCCCCCCCCC
34.6122167270
21PhosphorylationSTENTDESNHDPQFE
CCCCCCCCCCCCCCC
42.1322167270
32PhosphorylationPQFEPIVSLPEQEIK
CCCCCCCCCCHHHCC
38.6423927012
39UbiquitinationSLPEQEIKTLEEDEE
CCCHHHCCCCHHCHH
46.43-
50AcetylationEDEEELFKMRAKLFR
HCHHHHHHHHHHHHH
39.8523236377
50UbiquitinationEDEEELFKMRAKLFR
HCHHHHHHHHHHHHH
39.85-
54AcetylationELFKMRAKLFRFASE
HHHHHHHHHHHHHCC
37.4818527719
60PhosphorylationAKLFRFASENDLPEW
HHHHHHHCCCCCHHH
33.9319664994
68UbiquitinationENDLPEWKERGTGDV
CCCCHHHHHCCCCCC
35.5521890473
68AcetylationENDLPEWKERGTGDV
CCCCHHHHHCCCCCC
35.5525953088
68UbiquitinationENDLPEWKERGTGDV
CCCCHHHHHCCCCCC
35.5521890473
68MethylationENDLPEWKERGTGDV
CCCCHHHHHCCCCCC
35.5518527727
76UbiquitinationERGTGDVKLLKHKEK
HCCCCCCEEECHHHH
53.4921890473
76UbiquitinationERGTGDVKLLKHKEK
HCCCCCCEEECHHHH
53.4921890473
76AcetylationERGTGDVKLLKHKEK
HCCCCCCEEECHHHH
53.4925953088
79AcetylationTGDVKLLKHKEKGAI
CCCCEEECHHHHHHH
64.1718527735
97AcetylationMRRDKTLKICANHYI
HCCCCCHHHHCCCCC
40.7625953088
99GlutathionylationRDKTLKICANHYITP
CCCCHHHHCCCCCCC
2.7222555962
103PhosphorylationLKICANHYITPMMEL
HHHHCCCCCCCCEEC
13.2928796482
105PhosphorylationICANHYITPMMELKP
HHCCCCCCCCEECCC
9.66-
111UbiquitinationITPMMELKPNAGSDR
CCCCEECCCCCCCCC
23.9521906983
111UbiquitinationITPMMELKPNAGSDR
CCCCEECCCCCCCCC
23.9521890473
111AcetylationITPMMELKPNAGSDR
CCCCEECCCCCCCCC
23.9520167786
132GlutathionylationHADFADECPKPELLA
CCCCCHHCCCHHHEE
5.5922555962
134AcetylationDFADECPKPELLAIR
CCCHHCCCHHHEEHE
63.8823954790
134UbiquitinationDFADECPKPELLAIR
CCCHHCCCHHHEEHE
63.8821906983
134UbiquitinationDFADECPKPELLAIR
CCCHHCCCHHHEEHE
63.8821890473
137PhosphorylationDECPKPELLAIRFLN
HHCCCHHHEEHEECC
5.4827251275
150UbiquitinationLNAENAQKFKTKFEE
CCHHHHHHHHHHHHH
46.5521890473
150AcetylationLNAENAQKFKTKFEE
CCHHHHHHHHHHHHH
46.5519608861
150SuccinylationLNAENAQKFKTKFEE
CCHHHHHHHHHHHHH
46.55-
150SuccinylationLNAENAQKFKTKFEE
CCHHHHHHHHHHHHH
46.5519608861
150UbiquitinationLNAENAQKFKTKFEE
CCHHHHHHHHHHHHH
46.5521890473
152AcetylationAENAQKFKTKFEECR
HHHHHHHHHHHHHHH
58.8220167786
154AcetylationNAQKFKTKFEECRKE
HHHHHHHHHHHHHHH
51.9023749302
154UbiquitinationNAQKFKTKFEECRKE
HHHHHHHHHHHHHHH
51.90-
160AcetylationTKFEECRKEIEEREK
HHHHHHHHHHHHHHH
74.7730583473
179AcetylationGKNDHAEKVAEKLEA
CCCHHHHHHHHHHHH
47.7525953088
182UbiquitinationDHAEKVAEKLEALSV
HHHHHHHHHHHHHCC
62.2521890473
182UbiquitinationDHAEKVAEKLEALSV
HHHHHHHHHHHHHCC
62.2519608861
182AcetylationDHAEKVAEKLEALSV
HHHHHHHHHHHHHCC
62.2519608861
183UbiquitinationHAEKVAEKLEALSVK
HHHHHHHHHHHHCCC
41.7221906983
183AcetylationHAEKVAEKLEALSVK
HHHHHHHHHHHHCCC
41.7219608861
188PhosphorylationAEKLEALSVKEETKE
HHHHHHHCCCHHHHH
37.8923401153
190AcetylationKLEALSVKEETKEDA
HHHHHCCCHHHHHHH
46.5926051181
190UbiquitinationKLEALSVKEETKEDA
HHHHHCCCHHHHHHH
46.59-
190SumoylationKLEALSVKEETKEDA
HHHHHCCCHHHHHHH
46.5928112733
190SumoylationKLEALSVKEETKEDA
HHHHHCCCHHHHHHH
46.59-
193PhosphorylationALSVKEETKEDAEEK
HHCCCHHHHHHHHHH
40.6030108239
194AcetylationLSVKEETKEDAEEKQ
HCCCHHHHHHHHHHC
57.8026051181
200AcetylationTKEDAEEKQ------
HHHHHHHHC------
53.4630583485
265Phosphorylation-----------------------------------------------------------------------
-----------------------------------------------------------------------
27251275

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of RANG_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of RANG_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of RANG_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
IMB1_HUMANKPNB1physical
10473610
RAN_HUMANRANphysical
10811801
XPO1_HUMANXPO1physical
10601307
RAN_HUMANRANphysical
10779340
IMB1_HUMANKPNB1physical
10779340
RAN_HUMANRANphysical
9111043
MDM2_HUMANMDM2physical
12393906
RAN_HUMANRANphysical
22939629
RCC1_HUMANRCC1physical
22939629
RNA1_SCHPOrna1physical
11832950
IDHC_HUMANIDH1physical
22863883
PLST_HUMANPLS3physical
22863883
HERC5_HUMANHERC5physical
24693865
VATD_HUMANATP6V1Dphysical
26344197
GOLP3_HUMANGOLPH3physical
26344197
RAB1A_HUMANRAB1Aphysical
26344197
RAN_HUMANRANphysical
26344197
RNB3L_HUMANRANBP3Lphysical
26344197
TADBP_HUMANTARDBPphysical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of RANG_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-60, AND MASS SPECTROMETRY.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-150 AND LYS-183, AND MASSSPECTROMETRY.
Phosphorylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-60, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-7; THR-13; SER-14;THR-18 AND SER-21, AND MASS SPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-13; SER-14; THR-15;THR-18 AND SER-21, AND MASS SPECTROMETRY.

TOP